Versant Capital Management, Inc Novo Cure LTD Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Versant Capital Management, Inc holds 17,259 shares of NVCR stock, worth $313,941. This represents 0.05% of its overall portfolio holdings.
Number of Shares
17,259
Previous 13,699
25.99%
Holding current value
$313,941
Previous $244,000
25.82%
% of portfolio
0.05%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$221 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$205 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$163 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$100 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$94.9 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.91B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...